The Journal of Nutritional Biochemistry
Volume 21, Issue 9 , Pages 834-840 , September 2010

Lipoprotein metabolism mediates the association of MTP polymorphism with β-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis

  • Giovanni Musso

      Affiliations

    • Gradenigo Hospital, 10132 Turin, Italy
    • Corresponding Author InformationCorresponding author.
    • ,
  • Roberto Gambino

      Affiliations

    • Department of Internal Medicine, University of Turin, 10124 Turin, Italy
    • ,
  • Maurizio Cassader

      Affiliations

    • Department of Internal Medicine, University of Turin, 10124 Turin, Italy

Received 23 January 2009 ,Revised 8 June 2009 ,Accepted 15 June 2009.

References 

  1. Sattar N, Scherbakova O, Ford I, O'Reilly DS, Stanley A, Forrest E. Elevated alanine aminotransferase predicts new-onset Type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the West of Scotland Coronary Prevention Study. Diabetes. 2004;53:2855–2860
  2. Shibata M, Kihara Y, Taguchi M, Tashiro M, Otsuki M. Nonalcoholic fatty liver disease is a risk factor for Type 2 diabetes in middle-aged Japanese men. Diabetes Care. 2007;30:2940–2944
  3. Tushuizen ME, Bunck MC, Pouwels PJ, van Waesberghe JH, Diamant M, Heine RJ. Incretin mimetics as a novel therapeutic option for hepatic steatosis. Liver Int. 2006;26:1015–1017
  4. Marra F, Gastaldelli A, Svegliati Baroni G, Tell G, Tiribelli C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med. 2008;14:72–81
  5. Robertson RP, Harmon J, Tran POT, Poitout V. β-Cell glucose toxicity, lipotoxicity, and chronic oxidative stress in Type 2 diabetes. Diabetes. 2004;53:S119–S124
  6. Ustundag Y, Ozer IO, Yenidunia S. Oxidized low density lipoprotein in liver tissue samples of our NASH patients, alcoholic and chronic viral hepatitis cases. Gastroenterology. 2002;57:203
  7. Hoogeveen RC, Ballantyne CM, Bang H, Heiss G, Duncan BB, Folsom AR. Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of Type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Diabetologia. 2007;50:36–42
  8. Roehrich ME, Mooser V, Lenain V, Herz J, Nimpf J, Azhar S. Insulin-secreting β-Cell dysfunction induced by human lipoproteins. J Biol Chem. 2003;278:18368–18375
  9. Abderrhamani A, Niederhauser G, Favre D, Abdelli S, Ferdaoussi M, Yang JY. Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta-cells. Diabetologia. 2007;50:1304–1314
  10. Arsov T, Carter CZ, Nolan CJ, Petrovsky N, Goodnow CC, Teoh NC. Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice. Biochem Biophys Res Comm. 2006;342:1152–1159
  11. Namikawa C, Shu-Ping Z, Vyselaar JR, Nozaki Y, Nemoto Y. Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J Hepatol. 2004;40:781–786
  12. Gambino R, Cassader M, Pagano G, Durazzo M, Musso G. Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH?. Hepatology. 2007;45:1097–1107
  13. Karpe F, Lundahl B, Ehrenborg E, Eriksson P, Hamsten A. A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels. Arterioscler Thromb Vasc Biol. 1998;18:756–761
  14. Rubin D, Helwig U, Pfeuffer M, Schreiber S, Boeing H, Fisher E. A common functional exon polymorphism in the microsomal triglyceride transfer protein gene is associated with Type 2 diabetes, impaired glucose metabolism and insulin levels. J Hum Genet. 2006;51:567–574
  15. Niswender KD, Magnuson MA. Obesity and the β cell: lessons from leptin. J Clin Invest. 2007;117:2753–2756
  16. Ravikumar B, Carey PE, Snaar JE, Deelchand DK, Cook DB, Neely RD. Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and Type 2 diabetes. Am J Physiol Endocrinol Metab. 2005;288:E789–E797
  17. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis. 2001;21:3–16
  18. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137:1–9
  19. Chang Y, Ryu S, Sung E, Jang Y. Higher concentrations of alanine aminotransferase within the reference interval predict non-alcoholic fatty liver disease. Clin Chem. 2007;53:686–692
  20. Pisani P, Faggiano F, Krogh V, Palli D, Vineis P, Berrino F. Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centers. Int J Epidemiol. 1997;26(Suppl 1):S152–S160
  21. Carnovale E, Marletta . Food composition table. Istituto Nazionale della Nutrizione. Milano: EDRA; 1997;
  22. Pacini G, Mari A. Methods for clinical assessment of insulin sensitivity and beta-cell function. Best Pract Res Clin Endocrinol Metab. 2003;17:305–322
  23. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M. What is the best predictor of future type 2 diabetes?. Diabetes Care. 2007;30:1544–1548
  24. Tura A, Kautzky-Willer A, Pacini G. Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT. Diabetes Res Clin Pract. 2006;72:298–301
  25. Cobelli C, Toffolo GM, Man CD, Campioni M, Denti P, Caumo A. Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab. 2007;293:E1–E15
  26. Damcott CM, Pollin TI, Reinhart LJ, Ott SH, Shen H, Silver KD. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with Type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes. 2006;55:2654–2659
  27. Vittinghoff E, Shiboski SC, McCullouch CE, Glidden DV. Regression methods in biostatistics: linear, logistic, survival and repeated measures models. New York (NY): Springer Science+Business Media, Inc; Statistics for Biology and Health; 2005;
  28. Thabut D, Tazi KA, Bonnefont-Rousselot D, Aller M, Farges O, Guimont MC, et al. High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats. Hepatology. 2007;46:1893–1906
  29. Mathur A, Marine M, Lu D, Swartz-Basile DA, Saxena R, Zyromski NJ. A nonalcoholic fatty pancreas disease. HPB (Oxford). 2007;9:312–318
  30. Meier JJ, Gethmann A, Götze O, Gallwitz B, Holst JJ, Schmidt WE. Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans. Diabetologia. 2006;49:452–458

☆ DISCLOSURE: No author has any conflict of interest to disclose. This work was partly funded by the Piedmont Region Funds Comitato Interministeriale per la Programmazione Economica 2008.

PII: S0955-2863(09)00133-8

doi: 10.1016/j.jnutbio.2009.06.007

The Journal of Nutritional Biochemistry
Volume 21, Issue 9 , Pages 834-840 , September 2010

Article Tools

* Image Usage & Resolution